Tagatose
A rare sugar with about 90 percent of the sweetness of sucrose but a much smaller glycaemic effect. Meta-analyses of human trials confirm it blunts the post-meal glucose rise; evidence for weight loss or long-term metabolic benefit is much thinner.
Evidence last reviewed: August 2026
What the science says
- Post-meal glucose response Moderate evidence
A systematic review and meta-analysis of controlled human intervention trials of allulose and tagatose found reductions in postprandial glucose compared with sucrose or glucose. Trials were mostly short-term and acute.
- Replacing sugar in the diet Moderate evidence
A meta-analysis of fructose and its epimers, which includes tagatose, found favourable effects on postprandial carbohydrate metabolism when they replace other sugars. The benefit is a substitution effect rather than an active metabolic treatment.
- Longer-term metabolic outcomes Limited evidence
A systematic review of rare sugars in human trials concluded that evidence for sustained effects on HbA1c, body weight or lipids remains sparse and of low certainty. Most positive findings come from single-meal studies.
Dosage & safety
Scientific references
- Glycemic and cardiometabolic effects of rare sugars allulose and tagatose: a systematic review and meta-analysis of controlled human intervention trials
- Effect of fructose and its epimers on postprandial carbohydrate metabolism: A systematic review and meta-analysis
- Rare sugars and their health effects in humans: a systematic review and narrative synthesis of the evidence from human trials
Where to buy
Ships to 180+ countries · welcome discount for new customers
Referral link — this site may earn a commission on purchases.
Related in Heart & metabolic
- Vitamin B3 (Niacin) Limited evidence
- Vitamin K2 (MK-7) Limited evidence
- Chromium Limited evidence
- Potassium Strong evidence
- Vanadium Limited evidence
- L-Arginine Moderate evidence